Prize 202209PJT - Early Career Award in Cancer: An international randomized trial on neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma versus definitive chemoradiotherapy with salvage surgery as needed - The NEEDS Trial
Prize 202209PJT - Early Career Award in Cancer: An international randomized trial on neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma versus definitive chemoradiotherapy with salvage surgery as needed - The NEEDS Trial
奖 202209PJT - 癌症早期职业奖：食管鳞状细胞癌新辅助放化疗与根治性放化疗（根据需要进行挽救手术）的国际随机试验 - NEEDS 试验
批准号：
477684
负责人：
Lukovic Jelena
金额：
$1.82万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
已结题
起止时间：
2022-09-01 至 2023-09-01
中文摘要
翻译
食管癌是全球第六大癌症死亡原因。食管鳞状细胞癌（ESCC）占全球病例的90%，其治愈性治疗存在争议。手术候选者最好接受放化疗
英文摘要
Esophageal cancer is the 6th leading cause of cancer death worldwide. Curative treatment for esophageal squamous cell carcinoma (ESCC), representing 90% of cases globally, is controversial. Candidates for surgery are preferably treated with chemoradiother
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An international randomized trial on neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma versus definitive chemoradiotherapy with salvage surgery as needed - The NEEDS Trial
-
批准号：469430
-
项目类别：Operating Grants
-
资助金额：$132.08万
-
财政年份：2022
-
负责人：Lukovic Jelena
-
依托单位：
海外基金
